
Heron Therapeutics, Inc.
HRTXHealthcare|Biotechnology|US
$0.29
+0.01 (+4.64%)
Tangible Book / Share
$0.04
Cash / Share
$0.22
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (1)
Dec 2026
Est. completion
P1P2Solid Tumor
A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors
NCT07691775n=30
Awaiting Results (2)
Trials past primary completion date but still active — data readout may be imminent.
Jun 2024
P4
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
NCT05109312Recent Press Releases
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Oct 26, 2026 · GlobeNewsWire
SEC Filings (60)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 27, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 10, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 10, 2026 | 8-K | Material event | DocumentIndex |
| Jun 25, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 2, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 20, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 6, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 26, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 26, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 9, 2026 | 8-K | Material event | DocumentIndex |
| Nov 26, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 4, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 4, 2025 | 8-K | Material event | DocumentIndex |
| Oct 30, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 29, 2025 | 8-K | Material event | DocumentIndex |
| Oct 17, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 15, 2025 | 8-K | Material event | DocumentIndex |
| Sep 19, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Sep 16, 2025 | EFFECT | DocumentIndex | |
| Sep 16, 2025 | EFFECT | DocumentIndex | |
| Sep 9, 2025 | S-3 | Shelf registration | DocumentIndex |
| Sep 9, 2025 | S-3 | Shelf registration | DocumentIndex |
| Sep 9, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 28, 2025 | 8-K | Material event | DocumentIndex |
| Aug 15, 2025 | 8-A12B | DocumentIndex | |
| Aug 15, 2025 | 8-K | Material event | DocumentIndex |
| Aug 12, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 12, 2025 | 8-K | Material event | DocumentIndex |